Results 81 to 90 of about 174,990 (235)

Serum Bicarbonate And Survival In Peritoneal Dialysis (Pd): Comparison With Hemodialysis (Hd)

Kidney Research and Clinical Practice, 2012
Correction of metabolic acidosis is one of the goals of effective dialysis. The KDOQI guidelines recommend serum bicarbonate >22 meq/L irrespective of dialysis modality.
Tania Sharma, Kamyar Kalantar-Zadeh, Miklos Z Molnar, Allen Nissenson, Mahesh Krishnan, Rajnish Mehrotra   +5 more
doaj   +1 more source

Extreme morning chronotypes are often familial and not exceedingly rare: the estimated prevalence of advanced sleep phase, familial advanced sleep phase, and advanced sleep-wake phase disorder in a sleep clinic population. [PDF]

, 2019
Study objectivesReport the first prevalence estimates of advanced sleep phase (ASP), familial advanced sleep phase (FASP), and advanced sleep-wake phase disorder (ASWPD).
Ashbrook, Liza H, Curtis, Brian John, Finn, Laurel A, Fu, Ying-Hui, Jones, Christopher R, Ptáček, Louis J, Young, Terry   +6 more
core  

Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays [PDF]

, 2010
Basic-region leucine-zipper transcription factors (bZIPs) contain a segment rich in basic amino acids that can bind DNA, followed by a leucine zipper that can interact with other leucine zippers to form coiled-coil homo- or heterodimers.
Acharya A., Adya N., Amoutzias G. D., Basbous J., Bos T. J., Brown A. C., Campbell K. M., Chang Y. N., Chen W.-J., Chen Y. H., Countryman J., Cowell I. G., Daury L., Doi M., Ellison T. J., Gaudray G., Gerhard D. S., Grigoryan G., Hai T., Harbury P. B., Hardwick J. M., Hicks M. R., Hicks M. R., Hivin P., Hogan M., R., Hoover D. M., Huguier S., Ikushima S., Kataoka K., Kataoka K., Kataoka K., Katsuoka F., Kerppola T. K., Kuhlmann A.-S., Kutok J. L., Kvansakul M., Lai C.-K., Lefort S., Lemasson I., Levy A. M., Levy A. M., Lin S.-F., Lu R., Matsumoto J., Mesnard J. M., Moitra J., Nair V., Newman J. R. S., Oikarinen J., Parkin S. E., Petosa C., Pouponnot C., Qian Z., Qian Z., Rauscher F. J., Rossetto C., Ryseck R. P., Satou Y., Schepers A., Sinclair A. J., Suchodolski P. F., Thebault S., Thomas F. S., Ubeda M., van Straaten F., Vinson C. R., Vogt P. K., Witt A. E., Wu F. Y., Wu F. Y.   +69 more
core   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source

Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry

BMC Cardiovascular Disorders, 2017
Background Conflicting with clinical practice guidelines, recent studies demonstrated that serum potassium concentrations (SPC) of ≥4.5 mEq/l were associated with increased mortality in patients with acute myocardial infarction (AMI). This study examined
Miriam Giovanna Colombo, Inge Kirchberger, Ute Amann, Margit Heier, Christian Thilo, Bernhard Kuch, Annette Peters, Christa Meisinger   +7 more
doaj   +1 more source

Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report [PDF]

, 2020
Introduction: With the incredibly high incidence of Type 2 Diabetes in the current population of emergency department patients, it is critical for clinicians to understand the possible complications of the treatment of this disease.
Ault, Brian, Bonney, Caitlin, Earle, Matthew   +2 more
core  

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Adaptation Study of the Mindful Eating Questiionnare (MEQ) into Turkish

Bilişsel Davranışçı Psikoterapi ve Araştırmalar Dergisi, 2016
Adaptation Study of the Mindful Eating Questionnare (MEQ) into Turkish Objective: In this study we aimed to define the ‘mindful eating’ and discover the reliability and validity analyses of Mindful Eating Questionnare (MEQ) in Turkish sample, which has ...
Gizem KOSE, Muhittin TAYFUR, Inci BIRINCIOGLU, Aslihan DONMEZ   +3 more
doaj   +1 more source

Freedon study: Real‐life outcomes of cenobamate in different lines of treatment

Epilepsia, EarlyView.
Abstract Objectives Cenobamate is an antiseizure medication (ASM) with proven effectiveness in individuals with highly refractory epilepsy. This study investigated the effectiveness and tolerability of cenobamate in different treatment lines and a less refractory setting. Methods This was a multicenter, retrospective, observational study.
Vicente Villanueva, José María Serratosa, Alejandro Fernández‐Cabrera, Manuel Toledo, Beatriz González‐Giráldez, José C. Estevez, Juan Jesús Rodríguez Uranga, Maria Machio Castelló, Maria Dolores Castro‐Vilanova, Juan José Poza, Xiana Rodríguez‐Osorio, Kevin G. Hampel, Elena Fonseca, Francisco Javier López‐González, Mercedes Garcés, Laura Abraira, Jordi Ciurans, Daniel Campos‐Fernández, Estevo Santamarina, Juan María Sanchez‐Caro, Lucas Iacampo, Julia Renau, Miguel Ángel García‐Quesada, Carla Anciones, María Isabel Chamorro, Iratxe Maestro, Pablo Cabezudo, Raquel Calle, Jesús Macarron, Beatriz Cabezas, María Carrasco, María López, Marta Marín, Rosa Querol, Belén Baena, Vanessa García‐Morales, Samuel López‐Maza, Álvaro Juiz, Blanca Mercedes‐Alvarez, Carla Amarante, Ana del Villar, Ascensión Castillo, Marta Rubio‐Roy, Javier Martinez‐Poles, Asier Gómez‐Ibáñez, Beatriz Parejo‐Carbonell, Anabelén Martínez Garcia, Ignacio Carrera, Pablo Iriarte, Fátima Romero‐Aguilera, on behalf of the Pharmacological Therapy Working group of the Spanish Epilepsy Society and Freedon Group   +50 more
wiley   +1 more source